This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of York. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Andrei Arzumanov: Innovator in Hybrid Interfering RNA Technology
Introduction
Andrei Arzumanov is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of molecular biology, particularly in the development of innovative RNA technologies. His work has implications for various applications, including gene silencing and polymerase chain reactions.
Latest Patents
Arzumanov holds a patent for a hybrid interfering RNA molecule. This invention comprises a duplex RNA and a single-stranded DNA molecule, which is utilized in the ablation of mRNA and in polymerase chain reactions. His patent represents a significant advancement in the field of genetic research and therapeutic applications.
Career Highlights
Andrei Arzumanov is affiliated with the University of York, where he continues to engage in groundbreaking research. His work has garnered attention for its potential to influence the development of new therapeutic strategies in molecular biology.
Collaborations
Throughout his career, Arzumanov has collaborated with esteemed colleagues, including Ming Jiang and Josephine Anne Milner. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Andrei Arzumanov's contributions to hybrid interfering RNA technology exemplify the impact of innovative research in molecular biology. His work continues to pave the way for advancements in genetic research and therapeutic applications.